Minang Mintu Turakhia, M.D., M.S., is a distinguished medical professional who currently holds the positions of Chief Medical Officer, Chief Scientific Officer, and EVP of Product Innovation at iRhythm Technologies, Inc. Dr. Turakhia's career is marked by significant contributions to the field of cardiac electrophysiology and digital health. He earned his medical degree from the University of California, San Francisco, and a Master's degree in Health Services Research from Stanford University. His expertise spans clinical practice, research, and innovation, making him a pivotal figure in advancing the capabilities of iRhythm Technologies. At iRhythm Technologies, Dr. Turakhia plays a crucial role in driving the company's mission to improve the diagnosis and management of cardiac arrhythmias through innovative technology. His leadership has been instrumental in the development and refinement of the company's flagship product, the Zio service, which provides long-term continuous monitoring of heart rhythms. Under his guidance, iRhythm has expanded its research and development efforts, fostering collaborations with academic institutions and healthcare providers to enhance the clinical utility of their technology. Dr. Turakhia's work has not only improved patient outcomes but also positioned iRhythm as a leader in the digital health space. In addition to his corporate responsibilities, Dr. Turakhia is an active researcher and educator. He holds academic appointments at Stanford University and the University of California, San Francisco, where he contributes to the training of future healthcare professionals and conducts cutting-edge research in arrhythmia management. His numerous publications and presentations at international conferences underscore his commitment to advancing the field. Dr. Turakhia's multifaceted role at iRhythm Technologies exemplifies his dedication to integrating clinical expertise with technological innovation to revolutionize cardiac care.